Search | Uruboo

Komal Galande added blog Transfers
2026-01-08 08:10:15 -

Colorectal Cancer Treatment Market Progresses with Advances in Targeted and Immunotherapies
Regional Overview of Executive Summary Colorectal Cancer Treatment Market by Size and Share The expected CAGR of colorectal cancer treatment market is tend to be around 4% in the mentioned forecast period. The market is valued at USD 19 billion in 2022, and it would grow upto USD 26 billion by 2030. Colorectal Cancer Treatment Market analysis gives a clear idea on various segments...

0 Comments 0 Shares

Please log in to like, share and comment!
Komal Galande added blog Transfers
2026-01-21 06:52:49 -

Global Phenylketonuria Treatment Market Forecast Highlights Steady Size
Executive Summary Phenylketonuria (PKU) Treatment Market Size, Share, and Competitive Landscape The rise in the research in the field of genomics and bioinformatics and rise in the awareness amongst the people across the globe is expected to accelerate the market growth in the forecast period of 2022 to 2029. This Phenylketonuria (PKU) Treatment Market report has been...

0 Comments 0 Shares

Please log in to like, share and comment!
Komal Galande added blog International
2026-01-05 06:37:46 -

Nanomedicine Market Gains Traction with Breakthroughs in Targeted Drug Delivery
Global Executive Summary Nanomedicine Market: Size, Share, and Forecast The global nanomedicine market size was valued at USD 479.30 million in 2024 and is expected to reach USD 1,247.40 million by 2032, at a CAGR of 12.70% during the forecast period The complete Nanomedicine Market report is spread across a number of pages, list of tables &...

0 Comments 0 Shares

Please log in to like, share and comment!
Komal Galande added blog International
2026-01-02 07:36:06 -

RNA Therapeutics Market Accelerates with Breakthroughs in Precision Medicine
Global Executive Summary RNA Therapeutics Market: Size, Share, and Forecast During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 13.20%, primarily driven by the advancements in mRNA technology, increasing prevalence of chronic diseases, and rising investments in personalized medicine While preparing the first class RNA Therapeutics...

0 Comments 0 Shares

Please log in to like, share and comment!